Ophthalmic Case Studies and Novel Approach


In a small randomized controlled trial, production of aqueous tears and secretion of goblet cells increased following application of the Oculeve Intranasal Lacrimal Neurostimulator (Allergan).1 This handheld device works by delivering electrical stimulation to the anterior ethmoidal branch of the trigeminal nerve in the nasal cavities. It potentially offers a new mechanism for treating dry eye disease—now largely managed with artificial tears and anti-inflammatory agents.


    Related Conference of Ophthalmic Case Studies and Novel Approach

    March 18-19, 2024

    5th World Congress on Ophthalmology and Vision Science

    Zurich, Switzerland
    April 25-26, 2024

    24th Global Ophthalmologists Annual Meeting

    London, UK
    May 09-10, 2024

    7th International Eye and Vision Congress

    Barcelona, Spain
    May 16-17, 2024

    8th World Congress on Eye and Vision

    Rome, Italy
    June 13-14, 2024

    9th International Conference on Eye and Vision

    Barcelona, Spain
    October 10-11, 2024

    34th World Congress on Ophthalmology and Optometry

    Madrid, Spain
    October 10-11, 2024

    10th Global Ophthalmology Meeting

    Madrid, Spain

    Ophthalmic Case Studies and Novel Approach Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in